Navigation Links
Bethesda-Based NHSi Wins $2M Grant for Blood Technology
Date:5/26/2009

on a disposable microchip. This work is currently carried out in a partnership with Tulane University.

About New Health Sciences:

NHSi is a privately held company that is developing and commercializing two, strategically linked technologies. The first, Hemodyanamic Vascular Analysis ("HVA"), is a proprietary software and data-based diagnostic and disease management platform. HVA addresses a large and growing need in neurovascular medicine for more precise, inexpensive and safe diagnostic and disease management tools. The second, Hemanext, is novel technology to deliver red blood cells (RBCs) of higher efficacy for transfusion therapy, and at the same time, extend the shelf life of refrigerated RBCs. For more information on the company and other developments, visit www.newhealthsciences.com

    Contact:
    Martin Cannon (301) 493-4586 or Barret Hildebrand (301) 493-4562
    6303 Rockledge Drive, Suite 230
    Bethesda, MD 20817-1818


'/>"/>
SOURCE New Health Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
4. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
5. Chinese SFDA Grants Immtech Fast Track Status
6. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
7. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
8. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
9. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
10. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
11. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 The American Association ... Medical Design and Manufacturing has joined the AAHomecare Corporate ... Harvey Diamond have been actively involved in ... as it has quickly grown into a major global ... like Drive allows AAHomecare to increase efforts on behalf ...
(Date:9/19/2014)... UBM Medica US announces that  ... help oncologists and other clinicians gain a better understanding ... targeted therapies and immunotherapies, discusses some of the latest ... Every September, Blood Cancer Awareness Month ... blood cancers—helping to increase survival rates and improve the ...
(Date:9/19/2014)... WOONSOCKET, R.I. , Sept. 19, 2014 ... (NYSE: CVS ), will speak before the National ...  Merlo will discuss the company,s recent move to stop selling ... to shape the future of health. "Dramatic changes ... consumers, health care providers and government," Merlo has said. "CVS ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
... Dec. 1, 2011 Arbor Pharmaceuticals announced today that it ... the U.S. Food and Drug Administration (FDA).  The recently ... the FDA which provides seven years of market exclusivity. ... status for this product primarily due to the safety ...
... Novelos Therapeutics, Inc. (OTCBB: NVLT) , a pharmaceutical company ... announced the pricing of an underwritten public offering of 9,840,000 ...  Each unit consists of one share of common stock and ... warrants will have an exercise price of $0.60 per share ...
Cached Medicine Technology:Arbor Pharmaceuticals Announces Filing of First NDA 2Novelos Therapeutics Prices $5.9 Million Public Offering 2
(Date:9/21/2014)... New York (PRWEB) September 21, 2014 ... continue to move forward in Pennsylvania’s Philadelphia Court ... to court documents, the proceeding’s next monthly meeting ... Litigation, case number 100300296) , “Our Firm is ... Risperdal lawsuits in this litigation. We are pleased ...
(Date:9/21/2014)... 2014 Best Cheap Hosting USA, one ... Arvixe, Bluehost and GreenGeeks are the best Reseller hosting ... good reseller hosting supplier. Actually, these companies have outperformed ... customer support. People can get the best web hosting ... , According to the manager, reseller hosting is a ...
(Date:9/21/2014)... September 21, 2014 Market ... (CAS 49562-28-9) Industry, 2009-2019 is a professional ... Chinese Fenofibrate (CAS 49562-28-9) industry. The report ... (CAS 49562-28-9) including its classification, application and ... China’s top manufacturers of Fenofibrate (CAS 49562-28-9) ...
(Date:9/21/2014)... September 21, 2014 More than ... been added over the past month to a ... serious cardiovascular injuries caused by the dialysis concentrate, ... updated on September 15th shows 2,089 cases filed ... District Court, District of Massachusetts. These claims were ...
(Date:9/21/2014)... Recently, BambooIndustry.com, an experienced producer of natural bamboo items, ... ( http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels are very ... at discounted prices now, from 10 to 30 percent ... are available in many specifications; they are promised ... is finely manufactured by qualified workers. They are specially ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2
... go for the veggies , , WEDNESDAY, March 19 (HealthDay News) ... decidedly the carnivores while women prefer leaner, greener fare, a ... play a role, but "more obvious are cultural influences, which ... manly," according to Dr. David L. Katz, director of the ...
... The eighth annual American,Transplant Congress 2008 (ATC) ... field of basic and clinical transplantation,science and medicine. ... Canadian transplant and fittingly, the meeting travels to ... Centre in Toronto,Ontario hosts ATC 2008 from Saturday, ...
... PHILADELPHIA Researchers at the University of Pennsylvania School ... detailed look at the molecular pathways underlying sleep apnea, ... the National Institutes of Health. Sleep apnea is a ... which disruptions can occur dozens or even hundreds of ...
... of Surveyed Physicians Anticipate an Increase in the, Number of ... 19 Percent of Surveyed MCOs Will Not Add Novel ... According to a New Report ... Resources, one of the,world,s leading research and advisory firms for ...
... in Comprehensive Report Comparing SSO and ... Healthcare Industry, ANDOVER, Mass., March 19 ... Sign-On (SSO), announced today that it ranked ... comparing SSO and,context management vendors performance. The ...
... Eight out of 10,Americans are concerned about access ... cuts to physicians caring for Medicare patients,according to a ... (AMA). On July 1, Medicare payments to physicians will ... cuts will grow to about 40,percent while medical practice ...
Cached Medicine News:Health News:The Gender Divide Starts Over Dinner 2Health News:The Gender Divide Starts Over Dinner 3Health News:American Transplant Congress 2008 - Critical New Data to be Revealed in Toronto 2Health News:Molecular biology of sleep apnea could lead to new treatments 2Health News:One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines 2Health News:One-Third of U.S. Primary Care Physicians and Cardiologists Do Not Currently Prescribe Treatment to Meet HDL Cholesterol Targets as Recommended By National Guidelines 3Health News:Sentillion Ranked #1 Vendor in KLAS' Single Sign-On & Context Management Report 2Health News:Sentillion Ranked #1 Vendor in KLAS' Single Sign-On & Context Management Report 3Health News:New Poll Shows Public Worried About Medicare Cuts Impact on Seniors, Boomers - Wants Congress To Act 2
... The D.O.R.C. Associate® is an ... a Peristaltic and Venturi pump, allowing ... mode for Phaco or Vitrectomy procedures.,The ... is a microprocessor-controlled vacuum system that ...
The D.O.R.C. CryoStar is the smart cryosurgical system that combines optimal performance with state-of-the-art automation. simple for O.R. staff to operate and maintain throughout every procedure....
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media.(Sterile, 10 ml.)...
Medicine Products: